Jan 28, 2022, 17:18 PM by

Domainex Ltd., a leading provider of integrated drug discovery services to life science organisations globally, is delighted that Professors Daniel Longley, Tim Harrison and colleagues at Queen’s University Belfast have entered into a collaboration and licensing agreement with Ipsen. The agreement provides an exclusive licence to research, develop, manufacture and commercialise FLIP inhibitors. Domainex has supported the FLIP inhibitor programme from its inception.

Jan 28, 2022, 17:18 PM by

Positive Technologies today issued a new study that outlines the top 10 phishing topics used by cybercriminals throughout 2021, including: • New TV shows and movies • Banking issues • Travel and vacation • Dating • And cryptocurrency investments

Jan 28, 2022, 17:18 PM by

Jan 28, 2022, 17:18 PM by

Jan 27, 2022, 01:00 AM by User Not Found

Bio-IT World | Researchers at Mount Sinai and the University of Colorado are pursuing the possibilities that stem from predicting which COVID-19 patients are most likely to deteriorate over time. The hope is that this ability could help health care professionals more effectively triage patients and pair them with appropriate treatments to improve outcomes.

Jan 26, 2022, 01:00 AM by User Not Found

Bio-IT World | Efforts are underway to create an economy of data contributors and researchers who want to retain ownership of their contribution to longevity research as well as a proportionate share of the downstream profits from any resulting products. The ecosystem, and tokens underpinning it, goes by the name of Rejuve—definitionally, “the process of making somebody young again.”

Jan 25, 2022, 01:00 AM by User Not Found

Bio-IT World | After a decade of methodical preparation, Canada’s Ontario Brain Institute's (OBI) neuroinformatics platform, Brain-CODE, launched its open data sharing feature for global brain disorder research.

Jan 21, 2022, 01:00 AM by User Not Found

Bio-IT World | Life science researchers and drug discovery scientists today work in what, in my view, will be remembered in the future as the beginning of a “golden era” where the power of genetic information is connected to a wide range of other healthcare and lifestyle data to support better understanding of disease etiology, as well as the identification of candidates for drug targets and the discovery of new biomarkers that can be used to predict the presence or future development of a disease in an individual patient.

Jan 19, 2022, 01:00 AM by User Not Found

Bio-IT World | The nonprofit Consortium for Top-Down Proteomics recently proposed the Human Proteoform Project to generate a definitive reference set of the proteoforms produced from the genome. This will become a “seminal moment in science,” Neil Kelleher says, and the initiative is the next obvious step now that the Human Genome Project has provided the blueprint for how proteins get made.

Jan 18, 2022, 01:00 AM by User Not Found

Bio-IT World | Trends from the Trenches —Xiong Sean Liu is a Director at Novartis where he has been working to make inroads for AI in pharma. In Liu’s view, AI as a technology is already successful, but he also believes it is still in its early days for healthcare and there are still significant challenges for use. Data organization, for example, must be solved so that AI models can be put to best use. Liu and his team recently explored how electronic health records could be better populated and curated to facilitate clinical trials.

Jan 14, 2022, 01:00 AM by User Not Found

Bio-IT World | Closing out the genomic presentations at the JP Morgan Healthcare Conference, Christian Henry, president and CEO of Pacific Biosciences, had the dual challenges of presenting PacBio’s year and future strategies as well as answering claims and announcements other companies made. He persevered.

Jan 13, 2022, 01:00 AM by User Not Found

Bio-IT World | At the JP Morgan Healthcare Conference—being held virtually again this year—pharma and biotech companies gave overviews of their 2021 business and their views of the future. Here are the highlights we noted from presentations from Regeneron, 10X Genomics, and Invitae

Jan 12, 2022, 11:34 AM by

Rousselot®, Darling Ingredients’ health brand and the world’s leader of collagen-based solutions, today announced that it has partnered with the Terasaki Institute for Biomedical Innovation (TIBI), a California-based research institute focused on regenerative medicine.

Jan 12, 2022, 11:34 AM by

Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations

Jan 12, 2022, 11:34 AM by

PubHive Navigator SaaS platform now supports life science companies with workflow and information management needs across literature, aggregate reporting, and safety signal detection.

Jan 12, 2022, 11:34 AM by

Pharmaron Beijing Co., Limited, has announced today that it has acquired Aesica Pharmaceuticals Limited ("The Cramlington Site") from Recipharm group. This move will again help Recipharm streamline operations in line with its strategic goals and better align with customers' needs.

Jan 12, 2022, 11:34 AM by

Recipharm has today announced the sale of the solid dose manufacturing site at Fontaine-lès-Dijon, France, to Astrea Pharma. The move is a positive step in streamlining Recipharm's operations and consolidating its position as a top five global Contract Development and Manufacturing Organisation.

Jan 12, 2022, 11:34 AM by

PubHive Navigator expands safety and vigilance module, adding one-stop workflow and information management capabilities for aggregate reporting and authoring.

Jan 12, 2022, 11:34 AM by

Watson-Marlow Fluid-Technology Group (WMFTG) is pleased to confirm that it will be providing the sales and technical support for Flexicon in both Poland and the Czech Republic from January 2022.

Jan 12, 2022, 11:34 AM by

New Jersey-Based Health System Sees Increase in Online Appointment Bookings